Stocks Up as Bullar...
Health Care: Drugs
YM Biosciences Inc. (YMI: )
$2.94 -0.01 | -0.34%
02/08/13 - 04:01 PM ET
232.05K / 3.88M
Vol / Avg. Vol:2.94 / 2.95
Open / Prev. Close:2.94 - 2.95
Today's Range:1.45 - 2.95
52 Wk Range:n/a%
Performance YTD:TheStreet Rating:
Portfolios with YMI
- Portfolio NameUser Type
- UserMy stocks
- ContributorStocks Under-$10 Moving Hig...
- UserGopher Gold
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- Contributor10 Biotech Trades for Secon...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
Latest YMI Headlines from TheStreet
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- Breaking Up With Gilead Sciences 12.17.12 | 07:12 am
- The Long YM Bio Nightmare Has Ended -- Happily. 12.12.12 | 09:12 am
- Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena 12.07.12 | 07:12 am
- The Next Big Thing In Biotech: ASH Meeting
12.07.12 | 06:12 am - Biotech Stock Mailbag: YM Bio, Hemispherx, Navidea 09.28.12 | 07:09 am
- 7 Stocks Under $10 Soaring Higher 05.24.12 | 12:05 pm
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Cell Therapeutics Juggles Chainsaws To Distract Investors From Its Dead-End Course 04.19.12 | 03:04 pm
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
Press Releases for YMI
- Gilead Sciences Completes Acquisition Of YM BioSciences - Business Wire 02.08.13 | 04:02 pm
- Gilead Sciences Completes Acquisition Of YM BioSciences - PR Newswire 02.08.13 | 04:02 pm
- YM BioSciences Announces Receipt Of Final Court Order Approving The Plan Of Arrangement With Gilead Sciences - PR Newswire 02.05.13 | 10:02 am
- YM BioSciences Shareholders Approve Plan Of Arrangement With Gilead Sciences - PR Newswire 01.31.13 | 11:01 am
- YM BioSciences Inc. Plan Of Arrangement With Gilead Sciences, Inc. Endorsed By Leading Independent Proxy Advisors ISS And Glass Lewis - PR Newswire 01.18.13 | 07:01 am
- YM BioSciences Announces Record Date For Previously Announced Plan Of Arrangement - PR Newswire 12.21.12 | 12:12 pm
- Gilead Sciences To Acquire YM Biosciences - PR Newswire 12.12.12 | 10:12 am
- Gilead Sciences To Acquire YM BioSciences - Business Wire 12.12.12 | 08:12 am
- YM BioSciences Reports Divestiture Of Nimotuzumab Assets By CIMYM - PR Newswire 12.03.12 | 05:12 pm
- YM BioSciences Announces Election Of Dr. Kapil Dhingra To Its Board Of Directors - PR Newswire 11.20.12 | 05:11 pm
Partner Headlines for YMI
- Zacks' Voice of the People highlights opportunities with Ann Taylor, Team and YMI BioSciences - Press Releases - Zacks 01.19.12 | 09:01 am
- YM's Positive Results Have Incyte Investors Worried - Seeking Alpha 12.15.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Incyte JAK Inhibitor Awaits Certain Approval - Seeking Alpha 11.14.11 | 09:11 am
- 19 Small Cap Stocks Boosted By Institutional Buying - Seeking Alpha 10.11.11 | 08:10 am
- Hearing Positive Drug Chatter in YM Bio Sciences - Benzinga 08.19.11 | 01:08 pm
- Morning Market Losers - Benzinga 06.06.11 | 09:06 am
- Drugs to Watch at ASCO 2011 - Seeking Alpha 06.02.11 | 08:06 am
- 24 Stocks Under $5 Undervalued Relative to Target Price - Seeking Alpha 05.24.11 | 08:05 am
- ASCO 2011: Opportunities for Biotech Investor Success and Failure - Seeking Alpha 05.02.11 | 09:05 am
